Research never stops

Top Story

LAB282 accelerates with second round funding

Hamburg, Germany, 22 June 2017:
Evotec AG announced today that LAB282, the drug discovery BRIDGE between Oxford University, has made its second round of awards to support promising life sciences ideas emerging from the University.

- read more

Evotec announces strategic investment in Facio Therapies to support development of novel FSHD therapy

Hamburg, Germany, 20 June 2017: Evotec AG announced today that it will make a strategic investment as part of Facio Therapies' 2017 funding round together with Australian, European and North American members of the Facioscapulohumeral dystrophy community (Total volume: EUR 4.8 m).

- read more

Evotec receives European Mediscience Award for 'Company of the Year'

Hamburg, Germany, 16 June 2017: Evotec AG was awarded the European Mediscience Award for “Company of the Year”.

- read more
loading weather report
Loading weather report...


Jun 28, 2017 - BIOtech Japan

Sep 08, 2017 - 7th Annual Biotech Symposium

Company Presentation June

Building integrated and high-value drug discovery alliances
2017-06_Evotec_Company presentation_June